Acta Neuropathologica

, Volume 115, Issue 1, pp 1–4 | Cite as

Research into neurodegenerative disease: an entangled web of mice and men

Editorial

References

  1. 1.
    Cornwell J (2004) Explanations, styles of explanation in science. Oxford University Press, OxfordGoogle Scholar
  2. 2.
    Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537–548PubMedCrossRefGoogle Scholar
  3. 3.
    Duyckaerts C, Potier M-C, Delatour B (2008) Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathol. doi:10.1007/s00401-007-0312-8
  4. 4.
    Frank S, Clavaguera F, Tolnay M (2008) Tauopathy models and human neuropathology: similarities and differences. Acta Neuropathol. doi:10.1007/s00401-007-0291-9
  5. 5.
    Götz J, Chen F, van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Abeta 42 fibrils. Science 293:1491–1495PubMedCrossRefGoogle Scholar
  6. 6.
    Helmlinger D, Abou-Sleymane G, Yvert G, Rousseau S, Weber C, Trottier Y, Mandel JL, Devys D (2004) Disease progression despite early loss of polyglutamine protein expression in SCA7 mouse model. J Neurosci 24:1881–1887PubMedCrossRefGoogle Scholar
  7. 7.
    Iwabuchi K, Tsuchiya K, Uchihara T, Yagishita S (1999) Autosomal dominant spinocerebellar degenerations. Clinical, pathological, and genetic correlations. Rev Neurol (Paris) 155:255–270Google Scholar
  8. 8.
    Kahle P (2008) α-Synucleinopathy models and human neuropathology: similarities and differences. Acta Neuropathol. doi:10.1007/s00401-007-0302-x
  9. 9.
    Kato S (2008) Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences. Acta Neuropathol. doi:10.1007/s00401-007-0308-4
  10. 10.
    Lambrechts D, Robberecht W, Carmeliet P (2007) Heterogeneity in motoneuron disease. Trends Neurosci 30:536–544PubMedCrossRefGoogle Scholar
  11. 11.
    Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293:1487–1491PubMedCrossRefGoogle Scholar
  12. 12.
    Nicoll JA, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO (2003) Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 9:448–452PubMedCrossRefGoogle Scholar
  13. 13.
    Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:409–421PubMedCrossRefGoogle Scholar
  14. 14.
    Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer’s disease mouse model. Science 316:750–754PubMedCrossRefGoogle Scholar
  15. 15.
    Roizin L, Stellar S, Willson N, Whittier J, Liu JC (1974) Electron microscope and enzyme studies in cerebral biopsies of Huntington’s chorea. Trans Am Neurol Assoc 99:240–243PubMedGoogle Scholar
  16. 16.
    Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerrière A, Vital A, Dumanchin C, Feuillette S, Brice A, Vercelletto M, Dubas F, Frebourg T, Campion D (2006) APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Gen 38:24–26CrossRefGoogle Scholar
  17. 17.
    Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173–177PubMedCrossRefGoogle Scholar
  18. 18.
    Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) Alpha-synuclein locus triplication causes Parkinson’s disease. Science 302:841PubMedCrossRefGoogle Scholar
  19. 19.
    Uchihara T, Ikeda K, Tsuchiya K (2003) Pick body disease and Pick syndrome. Neuropathology 23:318–326PubMedCrossRefGoogle Scholar
  20. 20.
    Vonsattel J (2008) Huntington disease models and human neuropathology: similarities and differences. Acta Neuropathol. doi:10.1007/s00401-007-0306-6
  21. 21.
    Yamada M, Sato T, Tsuji S, Takahashi H (2008) CAG repeat disorder models and human neuropathology: similarities and differences. Acta Neuropathol. doi:10.1007/s00401-007-0287-5
  22. 22.
    Yamamoto A, Lucas JJ, Hen R (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington’s disease. Cell 101:57–66PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  1. 1.Department of NeurologyTokyo Metropolitan Institute for NeuroscienceTokyoJapan
  2. 2.Institute of NeuropathologyMünster University HospitalMünsterGermany

Personalised recommendations